The Division of Clinical Informatics and Digital Transformation (DoC-IT) is pleased to announce that Jinoos Yazdany, MD, MPH, has been named the inaugural Executive Director of AI Monitoring in Clinical Care. In her new role, Jinoos will lead IMPACC—the Impact Monitoring Platform for Clinical Care—a pioneering collaboration between UCSF Health and DoC-IT.

As executive director, Jinoos will spearhead the development of the foundational components of IMPACC: an advanced, real-time AI monitoring platform designed to continuously evaluate the efficacy, safety, fairness, and overall value of AI tools deployed at UCSF Health. A central focus of her role will also be to expand access to data on AI implementations, ensuring that UCSF’s research community can leverage these data to drive innovative research.

“AI is no longer just hype—it's fundamentally transforming the way we deliver healthcare. For example, the AI scribe I use in the clinic feels like a leap forward, freeing me from my keyboard so I can be fully present with my patients. What excites me most is ensuring we strategically deploy AI tools and evaluate whether they improve patient outcomes and increase the joy of practicing medicine.”
In the near term, IMPACC will deploy robust, readily implementable metrics to ensure AI tools are safe and effective, while simultaneously building a research pipeline to pioneer new monitoring approaches. Beyond UCSF, the open-source AI-monitoring metrics developed by the IMPACC team will enable institutions nationwide to learn from and tailor evidence-based strategies to their own needs.

Drawing on her extensive background in epidemiology, health services research, clinical informatics, and implementation science, Jinoos is uniquely positioned to drive innovations that enhance patient care. She serves as chief of the Division of Rheumatology at Zuckerberg San Francisco General Hospital (ZSFG) and is the UCSF Alice Betts Endowed Professor of Medicine. As a rheumatologist specializing in systemic lupus, she practices at ZSFG and co-directs the UCSF Health Lupus Clinic.

Throughout her distinguished career, she has built and led large-scale collaborations, and her visionary leadership has consistently fostered innovation and improved patient outcomes. This has included developing multiple nationally endorsed quality measures in rheumatology, establishing a widely used national registry in rheumatology called RISE, and, during the pandemic, launching the COVID-19 Global Rheumatology Alliance that brought together scientists from over 40 countries.

More People on the Move